BackC4 Therapeutics Overview

C4 Therapeutics Total Revenue

Track C4 Therapeutics's total revenue ($-12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

N/A

As of Sep 2026

Annual Revenue (TTM)

-$12.14M
↓ 197.77% YoY

Trailing 12 months ending Sep 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

C4 Therapeutics (CCCC) FAQ

As of the most recent data (September 2026), CCCC shows a total revenue of $-12M. That compares with $12M in the prior-year period — down 197.8% year over year. That is below the Healthcare sector average of $12T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCCC's total revenue is now $-12M (was $12M) — a 197.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether C4 Therapeutics is outperforming or lagging.

The Healthcare sector average total revenue is about $12T. C4 Therapeutics is at $-12M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how CCCC stacks up against individual peers as well.

Tracking CCCC's total revenue over time shows whether C4 Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $-12M That compares with $12M in the prior-year period — down 197.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has C4 Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $-12M) with ownership activity and broader fundamentals.